Has Kenneth Miller, MD received payments from drug or device companies?

Yes. Drug and device makers reported $935 in general payments to Kenneth Miller, MD across 29 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kenneth Miller, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kenneth Miller, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kenneth Miller, MD

Internal Medicine · Randolph, NJNPI 1558441238

Payments from drug & device makers

$935in general payments, 2019–2025

Across 29 payments — averaging $32.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Glaukos Corporation$322
AbbVie$196
Amarin Pharma, Inc.$157
Biohaven Pharmaceuticals, Inc.$120
Pfizer$85
Bayer$20
plus $34 from 2 others

What the payments were for

Food & beverage$88094%
Education$556%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Glaukos Corporation	2	$322
AbbVie(2 entities)	14	$196
Amarin Pharma, Inc.	8	$157
Biohaven Pharmaceuticals, Inc.	1	$120
Pfizer	1	$85
Bayer	1	$20
Novo Nordisk	1	$19
Dompe US, Inc.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$935 in reported general payments places this provider in the 65th percentile of 4,032 internal medicine providers in New Jersey.

See all internal medicine providers in New Jersey →

Medicare billing

Part B allowed, 2024

$419,121

Medicare patients

448

Services billed

5,025

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
FarxigaDapagliflozin Propanediol	60	$58,056
JanumetSitagliptin Phos/Metformin Hcl	55	$53,506
EliquisApixaban	68	$50,017
JardianceEmpagliflozin	28	$39,034
XareltoRivaroxaban	30	$22,660
MounjaroTirzepatide	13	$17,145
Rosuvastatin Calcium	520	$7,674
Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide	151	$7,061
EdarbyclorAzilsartan Med/Chlorthalidone	13	$6,162
Atorvastatin Calcium	511	$4,657
Metoprolol Succinate	283	$4,561
Dexlansoprazole DrDexlansoprazole	17	$3,899
SynthroidLevothyroxine Sodium	49	$3,772
Omeprazole	181	$3,576
Risedronate Sodium DrRisedronate Sodium	14	$3,571

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
PfizerEliquis	$85	$50,01768 claims
AbbVieSynthroid	$196	$3,77249 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 4,032 internal medicine providers in New Jersey.

Other internal medicine in Randolph

Sanjiv SharmaToms River$33.9M
Jeffrey CarsonNew Brunswick$13.8M
Samer HaddadHamilton$6.8M
Magdy ShenoudaWall$3.7M
Samar HameedLivingston$3.6M
Jane RohlfTrenton$2.7M
Mohammed NisarEdison$2.6M
Michael CasserNew Milford$2.2M
Sumitha ReddyHamilton$2M
Helio PedroNewark$1.8M

See the full list for New Jersey →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →